日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out

抗癌化合物筛选发现,抑制 Aurora 激酶 A 可作为一种手段,使 CRISPR/Cas9 基因编辑优于基因敲除。

Wilbie, Danny; Eising, Selma; Amo-Addae, Vicky; Walther, Johanna; Bosman, Esmeralda; Lei, Zhiyong; de Jong, Olivier G; Molenaar, Jan J; Mastrobattista, Enrico

Protocol to rapidly screen CRISPR-Cas9 gene editing outcomes in a cell population by mutating eGFP to a blue or non-fluorescent phenotype.

通过将 eGFP 突变为蓝色或非荧光表型,快速筛选细胞群体中 CRISPR-Cas9 基因编辑结果的方案

Wilbie Danny, Mastrobattista Enrico, de Jong Olivier Gerrit

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing

CRISPR/Cas在体内基因组编辑中的递送机制

Wilbie, Danny; Walther, Johanna; Mastrobattista, Enrico